|1.||Taché, Yvette: 2 articles (01/2015 - 07/2009)|
|2.||Rivier, Jean: 2 articles (01/2015 - 07/2009)|
|3.||Million, Mulugeta: 2 articles (01/2015 - 07/2009)|
|4.||Larauche, Muriel: 2 articles (01/2015 - 07/2009)|
|5.||Mulak, Agata: 1 article (01/2015)|
|6.||Biraud, Mandy: 1 article (01/2015)|
|7.||Adelson, David W: 1 article (07/2009)|
|8.||Brunnhuber, Stefan: 1 article (07/2009)|
|9.||Wang, Lixin: 1 article (07/2009)|
|10.||Pambukchian, Karina: 1 article (07/2009)|
01/01/2015 - "The sst1 agonist (3 and 10μg) prevented cortagine-induced hypersensitivity to CRD at each pressure while the sst2 agonist at 10μg reduced it. "
07/01/2009 - "Intraperitoneal (ip) cortagine also increased colonic permeability, activated proximal and distal colonic myenteric neurons, and induced visceral hypersensitivity to a second set of phasic colorectal distention (CRD). "
07/01/2009 - "Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways."
01/01/2015 - "We investigated the influence of the stable sst1-5 agonist, ODT8-SST and selective receptor subtype peptide agonists (3 or 10μg/mouse) injected intraperitoneally (ip) on visceral hypersensitivity in mice induced by repeated noxious colorectal distensions (four sets of three CRD, each at 55mmHg) or corticotropin-releasing factor receptor 1 agonist, cortagine given between two sets of graded CRD (15, 30, 45, and 60mmHg, three times each pressure). "
07/01/2009 - "In mice, cortagine (30 microg/kg ip) stimulated defecation by 7.8-fold, induced 60% incidence of diarrhea, and increased VMR to CRD. "
07/01/2009 - "Compared with vehicle, cortagine (10 microg/kg ip) significantly decreased the distal colonic transit time by 45% without affecting gastric transit, increased distal and transverse colonic contractility by 35.6 and 66.2%, respectively, and induced a 7.1-fold increase in defecation and watery diarrhea in 50% of rats during the first hour postinjection whereas intracerebroventricular (icv) cortagine (3 microg/rat) had lesser effects. "
|2.||CRF receptor type 1